Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and effects on the fetus and newborn: a meta-analysis. (Q46599065)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published in September 2005

Selective Serotonin Reuptake Inhibitor (SSRI) Use during Pregnancy and Effects on the Fetus and Newborn: A Meta-Analysis

Language	Label	Description	Also known as
English	Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and effects on the fetus and newborn: a meta-analysis.	scientific article published in September 2005	Selective Serotonin Reuptake Inhibitor (SSRI) Use during Pregnancy and Effects on the Fetus and Newborn: A Meta-Analysis

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16015372%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

0 references

Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and effects on the fetus and newborn: a meta-analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16015372%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16015372%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Delia M Vazquez

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16015372%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Keri A Lattimore

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16015372%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Steven M Donn

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16015372%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Alex R Kemper

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16015372%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Charles R Neal

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16015372%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

1 September 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16015372%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Journal of Perinatology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16015372%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16015372%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16015372%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

595-604

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16015372%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Comparing age at onset of major depression and other psychiatric disorders by birth cohorts in five US community populations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Depressive symptoms among pregnant women screened in obstetrics settings

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Obstetric complications in patients with depression--a population-based case-control study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Role of anxiety and depression in the onset of spontaneous preterm labor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Maternal prenatal depressive symptoms and spontaneous preterm births among African-American women in Baltimore, Maryland

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Depressive symptomatology during pregnancy: evidence for an association with decreased fetal growth in pregnancies of lower social class women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Serotonin as a developmental signal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Structural effects and neurofunctional sequelae of developmental exposure to psychotherapeutic drugs: experimental and clinical aspects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Serotonin transporter messenger RNA expression in neural crest-derived structures and sensory pathways of the developing rat embryo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Peripheral and central neurochemical effects of the selective serotonin reuptake inhibitors (SSRIs) in humans and nonhuman primates: assessing bioeffect and mechanisms of action

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Safety of fluoxetine during the first trimester of pregnancy: a meta-analytical review of epidemiological studies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Transplacental transfer of citalopram, fluoxetine and their primary demethylated metabolites in isolated perfused human placenta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Placental passage of antidepressant medications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Citalopram in pregnancy and lactation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Antidepressant discontinuation syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

The serotonin syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Neonate characteristics after maternal use of antidepressants in late pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Outcomes of prenatal antidepressant exposure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Delivery outcome after the use of antidepressants in early pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

The impact of depression and fluoxetine treatment on obstetrical outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Birth outcomes after prenatal exposure to antidepressant medication

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Neurodevelopment of children exposed in utero to antidepressant drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Perinatal outcome following third trimester exposure to paroxetine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Effects of first-trimester fluoxetine exposure on the newborn

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Fluoxetine and norfluoxetine concentrations in nursing infants and breast milk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

The Pharmacokinetics of Sertraline Excretion Into Human Breast Milk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Weight gain in infants breastfed by mothers who take fluoxetine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Paroxetine use throughout pregnancy: does it pose any risk to the neonate?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

21 January 2018

Placental transfer and fetal distribution of fluoxetine in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

7 January 2021

based on heuristic

inferred from DOI database lookup

Birth outcomes in pregnant women taking fluoxetine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of third trimester fluoxetine exposure on the newborn

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

7 January 2021

based on heuristic

inferred from DOI database lookup

Birth outcomes following prenatal exposure to fluoxetine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

7 January 2021

based on heuristic

inferred from DOI database lookup

Breastfeeding during maternal antidepressant treatment with serotonin reuptake inhibitors: infant exposure, clinical symptoms, and cytochrome p450 genotypes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211352

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46599065&oldid=2207970492"